Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QDEL - Quidel more quick diagnosis -- Ignore unavailable to you. Want to Upgrade?

To: David Wise who wrote (1409)	2/20/1998 12:34:00 PM
From: Dennis C	Respond to of 1693

There are two big block traded this morning: 82,5K at 3 1/4 and 82,5K at 3 3/16

To: David Wise who wrote (1409)	2/21/1998 5:13:00 PM
From: DeadHead	Read Replies (1) \| Respond to of 1693

> My premise was that I thought QDEL had the foresight to plan for replacement (via in-house development of whatever products the lawsuit settlement made them pay royalties on. As they migrated from supplying royalty imposed products to new products, margins would go up. < That's what I've been thinking too. I can't think of any other explanation for them caving in so easily to BDX's lawsuit. If the BXD technology they use is so basic that they couldn't evolve their products away from it, then I'm sure they would have fought the suit to the bitter end. Of course, the royalties will cost QDEL money in the short term.